Series C proceeds position Spectris for pivotal top-line data, regulatory submission, and launch planning ahead of a targeted ...

In today’s Pharmaceutical Executive Daily, Cognito Therapeutics and Nexcure secure new financing rounds to advance their pipelines, artificial intelligence and large language models reshape ...

Eli Lilly launches Employer Connect, a new platform linking employers with benefit administrators and a pharmacy network to ...

For commercial leaders, this environment challenges longstanding assumptions about pricing strategy, geographic prioritization, and commercial engagement. Three imperatives now face leaders seeking ...

Assumption-based tactics erode trust and can trigger both unsubscribes and regulatory scrutiny. Instead, consent signals ...

MFN pricing is still evolving as comments are due on the proposed rules for the globe and guard model. manufacturers have ...

AI-simulated HCP avatars enable unlimited, realistic practice with non-verbal cueing, reducing manager bandwidth constraints ...

She holds a PhD in organic chemistry from the University of Pennsylvania. In this Pharmaceutical Executive Academy discussion, Najat Khan, PhD, CEO of Recursion Pharmaceuticals and former chief data ...

Under the four-year agreement, Blackstone Life Sciences will provide Teva with $400 million to fund ongoing and future ...

In this Pharmaceutical Executive Academy discussion, Najat Khan, PhD, CEO of Recursion Pharmaceuticals and former chief data ...

UCB secured worldwide exclusive rights to develop, manufacture, and commercialize ATG-201, including access to Antengene’s ...

Bavarian Nordic CEO Paul Chaplin will step down by the end of 2026 after overseeing the company’s transformation into a ...